Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

International prostate symptoms score usage in a developing country.

Bowa K.

Ann Afr Med. 2013 Jul-Sep;12(3):174-5. No abstract available.

PMID:
24133758
2.

Problems with administration of international prostate symptom score in a developing community.

Ogwuche EI, Dakum NK, Amu CO, Dung ED, Udeh E, Ramyil VM.

Ann Afr Med. 2013 Jul-Sep;12(3):171-3. doi: 10.4103/1596-3519.117628.

3.

[Assessment of reproducibility and unidimensionality of International Prostate Symptom Score Japanese version].

Yoshimura A, Niimi M, Akaza H, Takeshima H, Otani M, Noguchi R, Ishikawa S, Ohashi Y.

Nihon Hinyokika Gakkai Zasshi. 1997 Dec;88(12):1013-20. Japanese. Erratum in: Nippon Hinyokika Gakkai Zasshi 1998 Mar;89(3):449.

4.

[A study on international prostate symptom score in the assessment of therapeutic effects and severity of symptoms due to benign prostatic hyperplasia].

Okajima E, Ozono S, Ota M, Tanaka M, Tani M, Hirao Y, Okajima E.

Nihon Hinyokika Gakkai Zasshi. 1995 Sep;86(9):1466-74. Japanese.

5.

Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.

Kok ET, Schouten BW, Bohnen AM, Groeneveld FP, Thomas S, Bosch JL.

J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.

PMID:
19091352
6.

Benign prostatic hyperplasia: treat or wait?

Davidson JH, Chutka DS.

J Fam Pract. 2008 Jul;57(7):454-63. Review.

PMID:
18625168
7.

Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: physician vs self.

Cam K, Akman Y, Cicekci B, Senel F, Erol A.

Prostate Cancer Prostatic Dis. 2004;7(1):41-4.

PMID:
14999237
8.
9.

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.

Roehrborn CG, McVary KT, Elion-Mboussa A, Viktrup L.

J Urol. 2008 Oct;180(4):1228-34. doi: 10.1016/j.juro.2008.06.079. Epub 2008 Aug 22.

PMID:
18722631
10.

[The international system of overall scoring assessment of the symptoms and quality of life of patients with benign prostatic hyperplasia].

Trapeznikova MF, Bazaev VV, Golubev GV, Mezentsev VA.

Urol Nefrol (Mosk). 1996 Mar-Apr;(2):2-4. Russian.

PMID:
8677545
11.

Comprehensive patient evaluation for benign prostatic hyperplasia.

Jepsen JV, Bruskewitz RC.

Urology. 1998 Apr;51(4A Suppl):13-8. Review.

PMID:
9586591
12.

Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia.

Barry MJ.

Urology. 2001 Dec;58(6 Suppl 1):25-32; discussion 32. Review.

PMID:
11750246
13.
14.

Questioning questions about symptoms of benign prostatic hyperplasia.

Hassler E, Krakau I, Häggarth L, Norlén L, Ekman P.

Fam Pract. 2001 Jun;18(3):328-32.

PMID:
11356743
15.

[Validation of a French adaptation of the international prostatic symptom score].

Grégoire JP, Moisan J, Labrecque M, Cusan L, Diamond P.

Prog Urol. 1996 Apr;6(2):240-9. French.

PMID:
8777417
16.

[New developments in the diagnosis of benign prostatic hyperplasia].

Vaida M, Novac B, Gheorghiu V, Novac C.

Rev Med Chir Soc Med Nat Iasi. 2006 Jan-Mar;110(1):88-96. Review. Romanian.

PMID:
19292085
17.

[The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia].

Luján Galán M, Páez Borda A, Martín Osés E, Llanes González L, Berenguer Sánchez A.

Arch Esp Urol. 1997 Oct;50(8):847-53. Spanish.

PMID:
9463282
18.

[Adaptation and validation in the French language of the International Score of Symptoms of Benign Prostatic Hypertrophy].

Sagnier PP, Richard F, Botto H, Teillac P, Dreyfus JP, Boyle P.

Prog Urol. 1994 Aug-Sep;4(4):532-8; discussion 539-40. French.

PMID:
7522745
19.

Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates.

Kok ET, Bohnen AM, Jonkheijm R, Gouweloos J, Groeneveld FP, Thomas S, Bosch JL.

Urology. 2006 Oct;68(4):784-9.

PMID:
17070353
20.

Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale.

Batista-Miranda JE, Molinuevo B, Pardo Y.

Urology. 2007 Feb;69(2):285-8.

PMID:
17320665

Supplemental Content

Support Center